Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia |
| |
Authors: | M C Prevost C Cariven M F Simon H Chap L Douste-Blazy |
| |
Affiliation: | INSERM Unité 101, Biochimie des Lipides, Hôpital Purpan, 31059 Toulouse, France |
| |
Abstract: | Hypoxia provokes pulmonary constriction and because PAF-acether is a very strong pulmonary constrictor, we looked for PAF-acether in lung alveolar lavage (LAL) with a biological method based on the measurement of rabbit platelet aggregation. We first demonstrated a PAF-acether secretion during bronchoalveolar lavage with sterile isotonic NaCl (pH 7.2). PAF-acether secretion was completely suppressed with isotonic NaCl containing 5 mM EDTA but lyso-PAF-acether was still present (1.9 +/- 0.55 nmoles). Upon hypobaric hypoxia, PAF-acether was detected in LAL (1.05 +/- 0.25 10(-2)nmoles). The amount of lyso-PAF-acether increased by 6 times (12.1 +/- 4.1 nmoles). These results are given for 10(4) nmoles phospholipids of LAL. They indicate that alveolar macrophages might be activated by hypobaric hypoxia, so they produce PAF-acether in the alveole. Such a process could be involved in the well-known bronchoconstriction accompanying hypoxia. |
| |
Keywords: | LAL lung alveolar lavage GPC PAF-acether platelet activating factor (1-0-alkyl-2-acetyl-GPC) lyso-PAF-acether (1-0-alkyl-GPC) CP creatine phosphate CPK creatinine phosphokinase indo indomethacin |
本文献已被 ScienceDirect 等数据库收录! |